Related Experiment Video
Updated: Jan 18, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Structural basis for LZTR1 recognition of RAS GTPases for degradation
Srisathiyanarayanan Dharmaiah1, Daniel A Bonsor1, Stephanie P Mo2
1National Cancer Institute RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Abstract:
The RAS family of small guanosine triphosphatases (GTPases) are tightly regulated signaling molecules that are further modulated by ubiquitination and proteolysis. Leucine Zipper-like Transcription Regulator 1 (LZTR1), a substrate adapter of the Cullin-3 RING E3 ubiquitin ligase, binds specific RAS GTPases and promotes their ubiquitination and proteasomal degradation. We present structures of LZTR1 Kelch domains bound to RIT1, MRAS, and KRAS, revealing interfaces that govern RAS isoform selectivity and nucleotide specificity. Biochemical and structural analyses of disease-associated Kelch domain mutations revealed three types of alterations: impaired substrate interaction, loop destabilization, and blade-blade repulsion. In cellular and mouse models, mutations disrupting substrate binding phenocopied LZTR1 loss, underscoring its substrate specificity. These findings define RAS recognition mechanisms by LZTR1 and suggest a molecular glue strategy to degrade oncogenic KRAS.
Insights
Leucine Zipper-like Transcription Regulator 1 (LZTR1) targets RAS GTPases for degradation. Understanding LZTR1’s RAS binding mechanisms reveals insights into RAS signaling and potential therapeutic strategies for KRAS-driven cancers.
Area of Science:
- Molecular Biology
- Structural Biology
- Cellular Signaling
Background:
- RAS GTPases are crucial signaling proteins regulated by ubiquitination and proteolysis.
- Leucine Zipper-like Transcription Regulator 1 (LZTR1) acts as a substrate adapter for Cullin-3 RING E3 ubiquitin ligase, targeting specific RAS proteins for degradation.
- Dysregulation of RAS signaling is implicated in various cancers.
Purpose of the Study:
- To elucidate the structural basis of LZTR1's interaction with RAS GTPases.
- To understand how LZTR1 achieves RAS isoform selectivity and nucleotide specificity.
- To investigate the functional consequences of disease-associated LZTR1 mutations.
Main Methods:
- X-ray crystallography to determine the structures of LZTR1 Kelch domains bound to RIT1, MRAS, and KRAS.
- Biochemical assays to analyze substrate interactions and mutation effects.
- Cellular and mouse models to assess the in vivo impact of LZTR1 mutations.
Main Results:
- Detailed structures reveal the interfaces governing RAS isoform and nucleotide specificity.
- Disease-associated mutations in LZTR1's Kelch domain lead to impaired substrate binding, loop destabilization, or blade-blade repulsion.
- Mutations disrupting substrate binding phenocopy LZTR1 loss in cellular and mouse models, confirming LZTR1's substrate specificity.
Conclusions:
- LZTR1 recognizes specific RAS GTPases through defined structural interfaces.
- Understanding these recognition mechanisms provides a foundation for developing targeted therapies.
- The findings suggest a potential molecular glue strategy to degrade oncogenic KRAS.
More Related Videos
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The Ras Gene
Ras is a...
Rab Cascades
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation

